Related references
Note: Only part of the references are listed.Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF: a systematic review and meta-analysis
George Griesinger et al.
FERTILITY AND STERILITY (2008)
The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study
Lawrence Engmann et al.
FERTILITY AND STERILITY (2008)
Prospective randomized study comparing luteal phase support for ICSI patients up to the first ultrasound compared with an additional three weeks
Mohamed A. Aboulghar et al.
HUMAN REPRODUCTION (2008)
Why do couples drop-out from IVF treatment? A prospective cohort study
M. F. G. Verberg et al.
HUMAN REPRODUCTION (2008)
Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome
Sergio Reis Soares et al.
HUMAN REPRODUCTION UPDATE (2008)
Cost-effectiveness of a mild compared with a standard strategy for IVF: a randomized comparison using cumulative term live birth as the primary endpoint
S. Polinder et al.
HUMAN REPRODUCTION (2008)
Serum anti-Mullerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles
Tsung-Hsien Leeh et al.
HUMAN REPRODUCTION (2008)
Low negative affect prior to treatment is associated with a decreased chance of live birth from a first IVF cycle
C. de Klerk et al.
HUMAN REPRODUCTION (2008)
Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation
B. C. J. M. Fauser et al.
HUMAN REPRODUCTION UPDATE (2008)
The ISMAAR proposal on terminology for ovarian stimulation for IVF
G. Nargund et al.
HUMAN REPRODUCTION (2007)
Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotrop in-releasing hormone antagonists and recombinant follicle-stimulating hormone
Efstratios M. Kolibianakis et al.
FERTILITY AND STERILITY (2007)
Are GnRH antagonists comparable to agonists for use in IVF?
J. A. Huirne et al.
HUMAN REPRODUCTION (2007)
The psychological impact more cycles of IVF with a treatment strategy of IVF failure after two or mild versus standard
C. de Klerk et al.
HUMAN REPRODUCTION (2007)
Coming soon to your clinic: patient-friendly ART
Guido Pennings et al.
HUMAN REPRODUCTION (2007)
Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction
Claudio Alvarez et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Psychological impact of infertility
Tara M. Cousineau et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2007)
A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial
Esther M. E. W. Heijnen et al.
LANCET (2007)
Women's emotional adjustment to IVF: a systematic review of 25 years of research
C. M. Verhaak et al.
HUMAN REPRODUCTION UPDATE (2007)
Among patients treated with FSH and GnRH analogues for in vitro fertilization, is the addition of recombinant LH associated with the probability of live birth? A systematic review and meta-analysis
E. M. Kolibianakis et al.
HUMAN REPRODUCTION UPDATE (2007)
Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis
E. M. Kolibianakis et al.
HUMAN REPRODUCTION UPDATE (2006)
The short- and long-term implications of maternal obesity on the mother and her offspring
P. M. Catalano et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2006)
GnRH antagonists in ovarian stimulation for IVF
B. C. Tarlatzis et al.
HUMAN REPRODUCTION UPDATE (2006)
A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer
Anthony M. Propst et al.
FERTILITY AND STERILITY (2006)
Timing luteal phase support in GnRH agonist down-regulated IVF/embryo transfer cycles
MH Mochtar et al.
HUMAN REPRODUCTION (2006)
The science behind 25 years of ovarian stimulation for in vitro fertilization
NS Macklon et al.
ENDOCRINE REVIEWS (2006)
Ovarian cyst formation following GnRH agonist administration in IVF cycles: incidence and impact
HS Qublan et al.
HUMAN REPRODUCTION (2006)
Treatment with the GnRH antagonist ganirelix prevents premature LH rises and luteinization in stimulated intrauterine insemination: results of a double-blind, placebo-controlled, multicentre trial
CB Lambalk et al.
HUMAN REPRODUCTION (2006)
GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis
G Griesinger et al.
HUMAN REPRODUCTION UPDATE (2006)
The psychological impact of mild ovarian stimulation combined with single embryo transfer compared with conventional IVF
C de Klerk et al.
HUMAN REPRODUCTION (2006)
Reasons for discontinuation of IVF treatment: a questionnaire study
M Rajkhowa et al.
HUMAN REPRODUCTION (2006)
A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome
EMEW Heijnen et al.
HUMAN REPRODUCTION UPDATE (2006)
A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists
EM Kolibianakis et al.
HUMAN REPRODUCTION (2005)
GnRH antagonists in ovarian stimulation: a treatment regimen of clinicians' second choice? Data from the German national IVF registry
G Griesinger et al.
HUMAN REPRODUCTION (2005)
A longitudinal, prospective study on emotional adjustment before, during and after consecutive fertility treatment cycles
CM Verhaak et al.
HUMAN REPRODUCTION (2005)
GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles:: a prospective randomized study
P Humaidan et al.
HUMAN REPRODUCTION (2005)
A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women with oral contraceptives before in vitro fertilization
LI Barmat et al.
FERTILITY AND STERILITY (2005)
Prolongation of follicular phase by delaying hCG administration results in a higher incidence of endometrial advancement on the day of oocyte retrieval in GnRH antagonist cycles
EM Kolibianakis et al.
HUMAN REPRODUCTION (2005)
The Concerns During Assisted Reproductive Technologies (CART) scale and pregnancy outcomes
H Klonoff-Cohen et al.
FERTILITY AND STERILITY (2004)
Why do couples discontinue in vitro fertilization treatment? A cohort study
C Olivius et al.
FERTILITY AND STERILITY (2004)
What is the most relevant standard of success in assisted reproduction? The next step to improving outcomes of IVF: consider the whole treatment
EMEW Heijnen et al.
HUMAN REPRODUCTION (2004)
Elevated progesterone at initiation of stimulation is associated with a lower ongoing pregnancy rate after IVF using GnRH antagonists
EM Kolibianakis et al.
HUMAN REPRODUCTION (2004)
A randomized, double-blind, multicentre clinical trial comparing starting doses of 150 and 200 IU of recombinant FSH in women treated with the GnRH antagonist ganirelix for assisted reproduction
HJ Out et al.
HUMAN REPRODUCTION (2004)
What is the most relevant standard of success in assisted reproduction? The singleton, term gestation, live birth rate per cycle initiated: the BESST endpoint for assisted reproduction
JK Min et al.
HUMAN REPRODUCTION (2004)
Assessment of reproductive ageing patterns by hormonal and ultrasonographic ovarian reserve tests
E Tufan et al.
HUMAN REPRODUCTION (2004)
Impact of overweight and underweight on assisted reproduction treatment
P Fedorcsák et al.
HUMAN REPRODUCTION (2004)
What is the most relevant standard of success in assisted reproduction? Is BESST (birth emphasizing a successful singleton at term) truly the best?
G Griesinger et al.
HUMAN REPRODUCTION (2004)
What is the most relevant standard of success in assisted reproduction? Is there a single 'parameter of excellence'?
A Pinborg et al.
HUMAN REPRODUCTION (2004)
Effects of vaginal progesterone administration starting on the day of oocyte retrieval on pregnancy rates
R Baruffi et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2003)
Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment
NGM Beckers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures
MA Aboulghar et al.
HUMAN REPRODUCTION UPDATE (2003)
A prospective study of predictive factors of ovarian response in 'standard' IVF/ICSI patients treated with recombinant FSH. A suggestion for a recombinant FSH dosage normogram
B Popovic-Todorovic et al.
HUMAN REPRODUCTION (2003)
A prospective randomized clinical trial comparing 150 IU and 225 IU of recombinant follicle-stimulating hormone (Gonal-F*) in a fixed-dose regimen for controlled ovarian stimulation in in vitro fertilization treatment
PYK Yong et al.
FERTILITY AND STERILITY (2003)
A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a 'standard' dose of 150 IU/day in 'standard' patients undergoing IVF/ICSI treatment
B Popovic-Todorovic et al.
HUMAN REPRODUCTION (2003)
Progesterone supplementation during early gestations after IVF or ICSI has no effect on the delivery rates: a randomized controlled trial
AN Andersen et al.
HUMAN REPRODUCTION (2002)
Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization
BC Fauser et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Delaying the initiation of progesterone supplementation results in decreased pregnancy rates after in vitro fertilization: a randomized, prospective study
SC Williams et al.
FERTILITY AND STERILITY (2001)
A prospective study of stress among women undergoing in vitro fertilization or gamete intrafallopian transfer
H Klonoff-Cohen et al.
FERTILITY AND STERILITY (2001)
A prospective, randomized comparison of two starting doses of recombinant FSH in combination with cetrorelix in women undergoing ovarian stimulation for IVF/ICSI
M Wikland et al.
HUMAN REPRODUCTION (2001)
Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation
M Fluker et al.
FERTILITY AND STERILITY (2001)
Does body mass index of infertile women have an impact on IVF procedure and outcome?
C Wittemer et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2000)
Ovarian stimulation with HMG:: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin
C Albano et al.
HUMAN REPRODUCTION (2000)
Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin)
F Olivennes et al.
FERTILITY AND STERILITY (2000)
Share Paper
